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• Questionnaires were distributed at six NHS trusts; 1041 individuals completed the 
questionnaires between 27th March and 9th June 2020. 
• Nearly two-thirds of participants reported recent sudden loss of sense of smell 
and/or taste. 
• Loss of sense of smell and/or taste was significantly associated with a positive 
Covid-19 test. 
• For those in who loss of smell and/or taste occurred at least four weeks prior to the 
survey, only half had fully recovered, indicating the need for further research into 
the long-term management of the sequelae of Covid-19 infection. 
• Increased awareness and recognition of these symptoms is crucial, in particular 
amongst healthcare personnel who need to be urgently tested and to self-isolate 
accordingly in order to reduce spread.   
 








On April 21, 2020, the Centers for Disease Control and Prevention (CDC) and on May 5, 
2020, the World Health Organisation added ‘new loss of taste or smell’ to their list of 
symptoms related to Covid-19, respectively. Public Health England (PHE) only included 
loss of smell and taste as official symptoms on May 20th. However, whether individual 
hospitals were including smell and taste disturbances in their initial work-up for Covid-19 
diagnosis is unknown.  
 
Several reports have now demonstrated the prevalence of these symptoms in Covid-19 
infected individuals with important implications on diagnosis and management1. Due to 
the high incidence of Covid-19 infection which has been reported in the healthcare setting, 
we sought to understand the symptomatology of a cohort of healthcare personnel in order 
to assess current management guidelines, including how many healthcare workers were 
permitted to continue working despite being infected.  
 
Materials and Methods 
 
Survey Design and Recruitment 
 
Anonymous questionnaires were distributed to staff at hospitals across six NHS trusts: 
Barts Health, Guy’s and St. Thomas’, James Paget University Hospital, Norfolk & Norwich 
University Hospital, Manchester University, and Wrightington, Wigan and Leigh. The 
study was advertised by trust-wide emails to all staff, which included access to an 
electronic link to the questionnaire. Participants completed the questionnaire online. 
 
Slight alterations to the survey format were utilised, due to logistical and practical reasons 
across the various trusts. Results from all trusts were pooled at the end of the recruitment 
period. Questionnaires were distributed and completed between 27 March 2020 and 9 
June 2020. A single questionnaire was distributed to three of the six trusts, while two 
questionnaires (baseline and follow-up) were distributed to the remaining three trusts. 
Question items were largely identical between the two methodologies; where different, 
questions were appropriately matched for analysis. This pertains to questions regarding 
whether participants had experienced the loss of sense of smell/taste within the past four 
weeks and whether or not they had recovered, which was either explicitly asked in the 
single questionnaire format or implied in the second methodology, on the basis of the 
baseline and follow-up questionnaires being completed four weeks apart. In addition, 
where relevant, only those who completed the follow-up survey were asked about 
qualitative smell dysfunction (i.e. distortion of smell, phantom smells, and sensations of 
burning/cooling/tingling in nose and/or mouth). The remainder of the questionnaires 
included items on age, sex, Covid-19 status and relevant symptoms as well as specific 
questions around chemosensory disturbances, such as a smell and taste rating, which 
were identical between the two methodologies.  
 
Descriptive statistical analysis was conducted on patient characteristics and logistic 
regression where odds ratios (with 95% confidence intervals and p-values) are presented. 
 
 
Smell and taste scores were compared between groups using the Mann-Whitney U test.  
Sensitivity and specificity of the loss of sense of smell/taste in relation to Covid-19 




Participant characteristics  
 
In total, 1041 healthcare workers from the six NHS trusts responded to our surveys from 
27 March 2020 – 9 June 2020. Sample characteristics are described in Table 1; 70.9% 
female (737/1039), 74.6% white (456/611), 75.1% work in direct contact with patients 
(489/651), 50.3% (524/1041) were aged ≤40 years and 5.6% (58/1041) aged over 60 
years. Overall, 306 (29.4%) participants had been tested for Covid-19: 208 (20.0% of 
total, 68.0% of tested) had a confirmed positive test and 98 (9.4% of total, 32.0% of tested) 
were negative; a further 315 (30.3%) had not been tested but suspected that they had 




In total, 62.3% (649/1041) of all participants reported losing their sense of smell/taste in 
the last 2 months, 16.6% of whom reported it as the only symptom (12 missing). Of the 
participants, who reported Covid-19 related symptoms (with or without a positive 
test/suspicion of infection and excluding loss of smell/taste), the most common 
experienced were fatigue (65.4%), cough (42.5%) and fever (40.2%). 720 participants 
reported the severity of their symptoms where 54.6% were mild, 43.8% moderate and 
1.7% severe. Overall, 385/793 (48.5%) had continued to work as normal during this time. 
Of the 272, who responded, 247 participants experienced at least one of the following 
symptoms: chemesthesis (i.e. sensations of burning, cooling or tingling) in nose or mouth 
(34.6%, 94/272), parosmia (42.3%, 115/272), and phantosmia (33.8%, 92/272). 
 
Self-reported experience with smell and taste dysfunction 
 
There was strong evidence of an association between losing the sense of smell/taste and 
Covid-19 (Table 2), participants who lost their sense of smell/taste were more likely to 
have a positive Covid-19 test (Odds Ratio OR=8.55, 95%CI: 4.69-15.58, p<0.001) or 
suspected Covid-19 infection (OR=14.55, 95%CI: 10.49-20.18, p<0.001), i.e. an 8½-fold 
increase in risk within the tested subgroup or a 14½-fold increase in risk when including 
both tested and non-tested participants. The sensitivity and specificity of smell/taste loss 
being symptoms of Covid-19 positive cases were 89.9% and 49.0%, respectively while 
the positive predictive and negative predictive values were 78.9% and 69.6%, 
respectively (Table 3). Similar results were observed when considering the scores 
participants gave with regards to their sense of smell/taste at its worst (0 none – 10 
normal), with markedly lower scores in the Covid-19 positive groups in terms of sense of 
smell (tested subgroup p<0.001; all participants p<0.001) and sense of taste (tested 




In 519 participants who had recently lost their sense of smell and responded to the 
question: “has it been 4 weeks since you lost your sense of smell/taste?” 88.2% (458/519) 
reported that it had been at least 4 weeks since they had lost their sense of smell/taste; 
9.9% (45/455) had not yet recovered, 38.7% (176/455) had recovered partially and 51.4% 
(234/455) had recovered completely (3 missing). Of those for whom loss of smell/taste 
occurred within the past 4 weeks (n=61), 19.5% (8/41) had not yet recovered, 58.5% 
(24/41) had recovered partially and 22.0% (9/41) had recovered completely (20 missing). 
Of the total cohort, the median loss was 14 days (range: 1–90), which excludes one 




This study demonstrates the very high prevalence of the loss of sense of smell and/or 
taste in healthcare personnel, which is significantly related to Covid-19 positivity. In 
addition, these symptoms may occur with or without the presence of other Covid-19 
related symptoms; in 16.6% of the cohort, the loss of sense of smell/taste was the only 
symptom. This indicates that a number of individuals deemed to be otherwise 
asymptomatic may in fact be highly contagious and should have been self-isolating.  
 
Importantly, our results demonstrate that nearly half of participants continued to work 
following the loss of sense of smell and/or taste. Some participants noted that when 
seeking advice regarding self-isolation from health authorities, they were told to continue 
working as loss of sense of smell and/or taste had yet to be recognised as official 
symptoms of COVID-19 (qualitative data not shown). Thus, it is likely that a large 
proportion of healthcare workers, who did continue to work, were in fact highly contagious 
at the time.  
 
Interestingly, while objective smell testing was beyond the scope of this study, we do note 
that symptom self-reporting (i.e. smell and taste rating) correlated with Covid-19 positivity.  
This has been similarly demonstrated by a group at King’s College London, where 
symptom tracking using a mobile app demonstrated that self-reporting of the loss of sense 
of smell, in addition to fatigue, cough and loss of appetite, may more accurately predict 
Covid-19 infection2. Previously, the correlation between subjective and objective 
assessment of smell function has been shown to be poor.3 However, more detailed 
questioning can improve the sensitivity of self-reported smell function as demonstrated 
by the US National Health and Nutrition Examination Survey (NHANES).4 Thus, while we 
cannot conclude whether self-reporting through our questionnaire can predict objective 
testing outcome, subjective assessment as an initial screen may be beneficial in the 
detection of Covid-19, especially given the typically sudden onset of the symptom, which 
is not as characteristic in olfactory dysfunction caused by other viruses. Efforts toward a 
validated, comprehensive questionnaire, which does correlate better with objective 
testing, would further this endeavour.  
 
Although both loss of sense of smell and taste improved over time in the majority, there 
is a need to address the longer-term effects of these symptoms, as nearly half of those 
who lost their sense of smell/taste at least four weeks prior to the survey had yet to 
 
 
recover at the time of the survey. The reported persistence of smell/taste disturbances 
requires improved management guidelines, and points to the need for more treatments 
to be evaluated through clinical trials. At present, guidelines published by ENT UK/British 
Rhinological Society recommend those with recent loss of smell and Covid-19 infection 
are managed by their GP with treatments suggested, which may include oral steroids 
after the initial two weeks.5 Further guidance can be found on supportive resources such 
as those available through Fifth Sense (www.fifthsense.org.uk).  
 
A limitation to self-reported questionnaires in general is the potential for 
response/selection and recall biases. Furthermore, since a repeat questionnaire was 
used at three sites, as opposed to the singular questionnaire as used at the remaining 
sites, it was not possible to perfectly match the questions and subsequent results. In 
addition, the design of the study allowed participants to opt out of certain questions. As 
such, there is necessarily missing data, which may impact the results.   
 
In addition, a further limitation of this study is that only 20% of respondents had proven 
Covid-19. An additional 30% of respondents reported a suspicion of Covid-19 infection. 
While Covid-19 infection in the latter group could not be confirmed, it is highly likely these 
individuals suffered from infection as the chance of sudden loss of smell and/or taste not 
due to Covid-19 infection is extremely rare. Indeed, a recent study demonstrated a 
positive rate of 87.5% for those who are tested within the first twelve days of isolated 
sudden loss of smell, further indicating that those who experience this isolated symptom 
are likely to have Covid-19 infection.5  
 
Moreover, it is important to note that, at the time of the study, the loss of sense of smell 
and/or taste had only recently emerged as potential cardinal symptoms of Covid-19 
infection. Therefore, Covid-19 testing was not readily available, nor at times 
recommended, for those experiencing these symptoms, as they had not at that time been 
recognised by Public Health England. As such, discounting self-reported Covid-19 
infection would certainly provide a limited evaluation of the population of healthcare 
workers being evaluated in this particular context.  
 
Ultimately, we believe that our results provide important further information and context 
to the current status of Covid-19 disease in a healthcare setting. Whilst we cannot 
estimate the true prevalence of smell and taste disturbance due to Covid-19, the high 
proportion reported here is in line with other large datasets reliant on self-reporting such 
as the Global Consortium for Chemosensory Research questionnaire2, 7-9. In contrast, a 
study in South Korea, which assessed only individuals who had a positive Covid-19 test, 
found that roughly 30% of patients with early stage or mild disease experienced 
anosmia/ageusia10. Nevertheless, while the true proportion of those who experience the 
loss of sense of smell/taste may be lower than observed in our study, our results indicate 
the importance of these symptoms and demonstrate their utility as part of targeted mass 
screening.  
 
It has been evident that healthcare workers frequently report loss of sense of smell,  
particularly in the absence of other symptoms and looking at other studies, it can now be 
 
 
regarded likely that most healthcare workers, who have suffered from a loss of sense of 
smell at the time of the first wave of the pandemic, are likely to have had Covid-19 
infection as the chance of sudden loss of olfactory function is so rare otherwise, especially 
with limited social contact in a national lockdown. Therefore, in order to prevent hospital 
transmission, it is imperative that the 20% rate of testing seen in the first wave must be 
improved upon, particularly as Europe faces a second wave of infection, which may be 
greater than the first. Increased awareness of Covid-19 symptomatology, in particular the 
loss of sense of smell, and implementation of due measures will certainly help to mitigate 





Table 1: Survey characteristics (N=1041) 
Table 2: Survey responses by Covid-19 coronavirus status (N=1041) 
Table 3: The loss of sense of smell and/or taste in predicting a positive Covid-19 test 
 
Online Supplemental Material 
 
Supplemental Material 1: Initial Questionnaire and Follow Up Questionnaire 




The data that support the findings of this study are available from the corresponding 
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Characteristic/Question  Category n (%) 
Age 
30 or under 251 (24.1) 
31-40 273 (26.2) 
41-50 244 (23.4) 
51-60 215 (20.7) 
Over 60 58 (5.6) 
Gender 
(n=1039) 
Female 737 (70.9) 
Male 301 (29.0) 
Non-binary 1 (0.1) 
Ethnicity 
(n=611) 
White 456 (74.6) 
Other 155 (25.4) 
NHS Trust 
Barts Health 273 (26.2) 
Guy's and St Thomas'  86 (8.3) 
James Paget University Hospitals 63 (6.1) 
Norfolk & Norwich University 
Hospital 
91 (8.7) 
Manchester University 428 (41.1) 
Wrightington, Wigan and Leigh  100 (9.6) 
Does your work involve 
direct patient contact? 
(n=651) 
No 162 (24.9) 
Yes 489 (75.1) 
Covid-19 Coronavirus 
Status? 
Negative tested 98 (9.4) 
Negative opinion 420 (40.3) 
Positive opinion 315 (30.3) 
Positive tested 208 (20.0) 
TOTAL 1041 (100.0) 
 























Have you suddenly lost your 
sense of smell/taste in the 
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How would you rate your 
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If not ongoing, how long did 










































































If you have suffered 




























































































































































































































Has it been ≥4 weeks since 


































Has your sense of smell 



















































































#did not complete follow-up questionnaire; *excludes 116 participants who reported ongoing symptoms; NA: not applicable 
 






 Tested positive Tested negative 
Reported loss of smell/taste 187 50 





Positive Predictive Value 






Table 3:  The loss of sense of smell and/or taste in predicting a positive Covid-19 test. 
 
